| | ceRNAs | Shared targeting miRNA(s) | Involved in disease |
| PTEN
and ZEB2 | miR-181, miR-200b, miR-25, and miR-92 | Melanoma [11] |
| PTEN
and CNOT6L (miR-17, 19a, 19b, 20a, 20b, and 106b)
VAPA (miRs 17, 19a, 20a, 20b, 26b, 106a, and 106b) | miRs 17, 19a, 20a, 20b, 26b, 106a, 106b, and 19b | Prostate cancer [12] |
| PTEN
and 13 ceRNAs including RB1, NRAS, KLF6, HIF1A, HIAT1, CTBP2, and TNKS2 | It is predicted that PTEN and RB1 share MRE for 32 common miRNAs [7] | Glioblastoma [13] |
| CD44
and CDC42 | miR-216a, miR-330, and miR-608 | Breast cancer and many other cancers [14] |
| Versican
and Rb1
PTEN | miR-199a-3p and miR-144 | Breast cancer [15] |
| PTEN
and PTENP1 | miR-19b and miR-20a | Controls downstream PI3K signalling and cell proliferation in several cancers [8] |
| PRKACB
and HULC | miR-372 | Hepatocellular carcinoma [16] |
| PTCSC3
and targets of miR-574-5p | miR-574-5p | Thyroid cancer [17] |
| LMNA
and 17 ceRNAs (predicted) | 11 miRNAs including miR-9, miR-34a, miR-539, miR-449a, and miR-671 [16] | Hutchinson-Gilford progeria syndrome [18] |
| | HSUR (HVS) | miRNA-27 | Controls host-virus interaction in HVS infected T cells [19] |
|
|
